ReviewResults and problems in cell differentiation2026
Exploring Chronic Rejection in Organ Transplantation Through Computational Modeling.
Review in Results and problems in cell differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic rejection remains a significant challenge in solid organ transplantation, contributing to graft dysfunction and eventual failure despite advances in immunosuppressive therapies. Computational modeling has emerged as a powerful tool for understanding chronic rejection mechanisms, enhancing diagnostic precision, and identifying novel therapeutic targets. This chapter explores various computational approaches, including artificial intelligence, machine learning, ordinary differential equations, partial differential equations, agent-based models, and gene network analysis applied to solid organ transplantation: kidney, liver, heart, and lung. While computational models offer numerous advantages, including cost-effectiveness and the ability to integrate multi-omics data, challenges remain in terms of data quality, standardization, and clinical validation. Bridging these gaps will require comprehensive longitudinal studies and the development of hybrid models that combine diverse computational techniques. Emerging technologies such as single-cell transcriptomics and spatial genomics hold promise for enhancing predictive accuracy and understanding cellular heterogeneity. As computational methods evolve, their integration with experimental research will be essential for developing precision medicine strategies to improve long-term graft survival.
Indexed as
Identifiers
41479021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.